Analystreport

Ra Pharmaceuticals Inc (NASDAQ: RARX) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.

RA PHARMACEUTICALS  (RARX) 
Last ra pharmaceuticals earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rapharma.com/news-investors